Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Advanced basal cell carcinoma: therapeutic options and considerations for patient care. Introduction.

Beer KR, Beer MS.

J Drugs Dermatol. 2013 Oct;12(10 Suppl):s146. No abstract available.

PMID:
24085059
2.

Granuloma annulare masquerading as erythema multiforme.

Beer K, Beer MS, Appelbaum D.

J Drugs Dermatol. 2013 Jun 1;12(6):694-7.

PMID:
23839189
3.

Host status of commercial mango cultivars to Thaumatotibia leucotreta (Lepidoptera: Tortricidae) in South Africa.

Grové T, De Beer MS, Joubert PH.

J Econ Entomol. 2012 Dec;105(6):1954-62.

PMID:
23356058
4.

Developing a systems approach for Thaumatotibia leucotreta (Lepidoptera: Tortricidae) on 'Hass' avocado in South Africa.

Grové T, De Beer MS, Joubert PH.

J Econ Entomol. 2010 Aug;103(4):1112-28.

PMID:
20857718
5.

Partnership between small biotech and big pharma.

Wiederrecht GJ, Hill RG, Beer MS.

IDrugs. 2006 Aug;9(8):560-4.

PMID:
16871465
6.

Aminoalkyl phenyl sulfones--a novel series of 5-HT7 receptor ligands.

Raubo P, Beer MS, Hunt PA, Huscroft IT, London C, Stanton JA, Kulagowski JJ.

Bioorg Med Chem Lett. 2006 Mar 1;16(5):1255-8. Epub 2005 Dec 7.

PMID:
16337790
7.

Genetic knockout and pharmacological blockade studies of the 5-HT7 receptor suggest therapeutic potential in depression.

Guscott M, Bristow LJ, Hadingham K, Rosahl TW, Beer MS, Stanton JA, Bromidge F, Owens AP, Huscroft I, Myers J, Rupniak NM, Patel S, Whiting PJ, Hutson PH, Fone KC, Biello SM, Kulagowski JJ, McAllister G.

Neuropharmacology. 2005 Mar;48(4):492-502.

PMID:
15755477
8.

Native and recombinant human Edg4 receptor-mediated Ca(2+) signalling.

Simpson PB, Villullas IR, Schurov I, Kerby J, Millard R, Haldon C, Beer MS, McAllister G.

Assay Drug Dev Technol. 2002 Nov;1(1 Pt 1):31-40.

PMID:
15090154
9.

Thiazoles and thiopyridines: novel series of high affinity h5HT(7) ligands.

Thomson CG, Beer MS, Curtis NR, Diggle HJ, Handford E, Kulagowski JJ.

Bioorg Med Chem Lett. 2004 Feb 9;14(3):677-80.

PMID:
14741267
10.

The hypothermic effect of 5-CT in mice is mediated through the 5-HT7 receptor.

Guscott MR, Egan E, Cook GP, Stanton JA, Beer MS, Rosahl TW, Hartmann S, Kulagowski J, McAllister G, Fone KC, Hutson PH.

Neuropharmacology. 2003 Jun;44(8):1031-7.

PMID:
12763096
11.

N-Arylsulfonylindole derivatives as serotonin 5-HT(6) receptor ligands.

Russell MG, Baker RJ, Barden L, Beer MS, Bristow L, Broughton HB, Knowles M, McAllister G, Patel S, Castro JL.

J Med Chem. 2001 Nov 8;44(23):3881-95.

PMID:
11689074
12.

Edg2 receptor distribution in adult rat brain.

Handford EJ, Smith D, Hewson L, McAllister G, Beer MS.

Neuroreport. 2001 Mar 26;12(4):757-60.

PMID:
11277579
13.

A high-throughput glow-type aequorin assay for measuring receptor-mediated changes in intracellular calcium levels.

George SE, Schaeffer MT, Cully D, Beer MS, McAllister G.

Anal Biochem. 2000 Nov 15;286(2):231-7.

PMID:
11067745
14.

Edg2 receptor functionality: gialpha1 coexpression and fusion protein studies.

McAllister G, Stanton JA, Salim K, Handford EJ, Beer MS.

Mol Pharmacol. 2000 Aug;58(2):407-12.

PMID:
10908309
15.

EDG receptors as a therapeutic target in the nervous system.

Beer MS, Stanton JA, Salim K, Rigby M, Heavens RP, Smith D, Mcallister G.

Ann N Y Acad Sci. 2000 Apr;905:118-31.

PMID:
10818448
16.

4-Hydroxy-1-[3-(5-(1,2,4-triazol-4-yl)-1H-indol-3-yl)propyl]piperidines: selective h5-HT1D agonists for the treatment of migraine.

Bourrain S, Neduvelil JG, Beer MS, Stanton JA, Showell GA, MacLeod AM.

Bioorg Med Chem Lett. 1999 Dec 6;9(23):3369-74.

PMID:
10612601
17.

3-[3-(Piperidin-1-yl)propyl]indoles as highly selective h5-HT(1D) receptor agonists.

Russell MG, Matassa VG, Pengilley RR, van Niel MB, Sohal B, Watt AP, Hitzel L, Beer MS, Stanton JA, Broughton HB, Castro JL.

J Med Chem. 1999 Dec 2;42(24):4981-5001.

PMID:
10585208
18.

Parallel synthesis of 3-aryloxy-2-propanolamines and evaluation as dual affinity 5-HT(1A) and 5-HT re-uptake ligands.

van Niel MB, Beer MS, Castro JL, Cheng SK, Evans DC, Heald A, Hitzel L, Hunt P, Mortishire-Smith R, O'Connor D, Watt AP, MacLeod AM.

Bioorg Med Chem Lett. 1999 Nov 15;9(22):3243-8.

PMID:
10576696
19.

2,7-diazabicyclo[3.3.0]octanes as novel h5-HT receptor agonists.

Russell MG, Beer MS, Stanton JA, Sohal B, Mortishire-Smith RJ, Castro JL.

Bioorg Med Chem Lett. 1999 Sep 6;9(17):2491-6.

PMID:
10498195
20.

Fluorination of 3-(3-(piperidin-1-yl)propyl)indoles and 3-(3-(piperazin-1-yl)propyl)indoles gives selective human 5-HT1D receptor ligands with improved pharmacokinetic profiles.

van Niel MB, Collins I, Beer MS, Broughton HB, Cheng SK, Goodacre SC, Heald A, Locker KL, MacLeod AM, Morrison D, Moyes CR, O'Connor D, Pike A, Rowley M, Russell MG, Sohal B, Stanton JA, Thomas S, Verrier H, Watt AP, Castro JL.

J Med Chem. 1999 Jun 17;42(12):2087-104.

PMID:
10377215
21.

Vasoconstriction in human isolated middle meningeal arteries: determining the contribution of 5-HT1B- and 5-HT1F-receptor activation.

Razzaque Z, Heald MA, Pickard JD, Maskell L, Beer MS, Hill RG, Longmore J.

Br J Clin Pharmacol. 1999 Jan;47(1):75-82.

22.

3-(Piperazinylpropyl)indoles: selective, orally bioavailable h5-HT1D receptor agonists as potential antimigraine agents.

Chambers MS, Street LJ, Goodacre S, Hobbs SC, Hunt P, Jelley RA, Matassa VG, Reeve AJ, Sternfeld F, Beer MS, Stanton JA, Rathbone D, Watt AP, MacLeod AM.

J Med Chem. 1999 Feb 25;42(4):691-705.

PMID:
10052976
23.

Synthesis and serotonergic activity of 3-[2-(pyrrolidin-1-yl)ethyl]indoles: potent agonists for the h5-HT1D receptor with high selectivity over the h5-HT1B receptor.

Sternfeld F, Guiblin AR, Jelley RA, Matassa VG, Reeve AJ, Hunt PA, Beer MS, Heald A, Stanton JA, Sohal B, Watt AP, Street LJ.

J Med Chem. 1999 Feb 25;42(4):677-90.

PMID:
10052975
24.

In vitro visualization of 5-HT receptors in rat brain using [35S]GTP gamma S binding.

Beer MS, Stanton JA.

Ann N Y Acad Sci. 1998 Dec 15;861:265. No abstract available.

PMID:
9928281
25.

Pharmacological characterisation of a cloned dog 5-HT1B receptor cell line.

Beer MS, Heald MA, McAllister G, Stanton JA.

Eur J Pharmacol. 1998 Oct 30;360(1):117-21.

PMID:
9845281
26.

Enhancement of oral absorption in selective 5-HT1D receptor agonists: fluorinated 3-[3-(piperidin-1-yl)propyl]indoles.

Castro JL, Collins I, Russell MG, Watt AP, Sohal B, Rathbone D, Beer MS, Stanton JA.

J Med Chem. 1998 Jul 16;41(15):2667-70. No abstract available.

PMID:
9667955
27.

Selective, orally active 5-HT1D receptor agonists as potential antimigraine agents.

MacLeod AM, Street LJ, Reeve AJ, Jelley RA, Sternfeld F, Beer MS, Stanton JA, Watt AP, Rathbone D, Matassa VG.

J Med Chem. 1997 Oct 24;40(22):3501-3. No abstract available.

PMID:
9357515
28.

3-[2-(Pyrrolidin-1-yl)ethyl]indoles and 3-[3-(piperidin-1-yl)propyl]indoles: agonists for the h5-HT1D receptor with high selectivity over the h5-HT1B subtype.

Castro JL, Street LJ, Guiblin AR, Jelley RA, Russell MG, Sternfeld F, Beer MS, Stanton JA, Matassa VG.

J Med Chem. 1997 Oct 24;40(22):3497-500. No abstract available.

PMID:
9357514
29.

Differential effects of 5-HT1B/1D receptor agonists on neurogenic dural plasma extravasation and vasodilation in anaesthetized rats.

Shepherd SL, Williamson DJ, Beer MS, Hill RG, Hargreaves RJ.

Neuropharmacology. 1997 Apr-May;36(4-5):525-33.

PMID:
9225277
30.

Characterisation of a cloned human 5-HT1A receptor cell line using [35S]GTP gamma S binding.

Stanton JA, Beer MS.

Eur J Pharmacol. 1997 Feb 12;320(2-3):267-75.

PMID:
9059863
31.

Autoradiographic localization of 5-CT-insensitive 5-HT1-like recognition sites in guinea pig and rat brain.

Stanton JA, Middlemiss DN, Beer MS.

Neuropharmacology. 1996 Feb;35(2):223-9.

PMID:
8734492
32.

Synthesis and serotonergic activity of N,N-dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethylamine and analogues: potent agonists for 5-HT1D receptors.

Street LJ, Baker R, Davey WB, Guiblin AR, Jelley RA, Reeve AJ, Routledge H, Sternfeld F, Watt AP, Beer MS, et al.

J Med Chem. 1995 May 12;38(10):1799-810.

PMID:
7752204
33.

[3H]L-694,247 labels the 5-HT1D beta receptor in pig caudate membranes.

Heald A, Stanton JA, Osborne SA, Middlemiss DN, Beer MS.

Eur J Pharmacol. 1994 Oct 24;264(2):213-6.

PMID:
7851485
34.

Synthesis and biological activity of 3-[2-(dimethylamino)ethyl]-5-[(1,1-dioxo-5-methyl-1,2,5-thiadiazolidin- 2-yl)-methyl]-1H-indole and analogues: agonists for the 5-HT1D receptor.

Castro JL, Baker R, Guiblin AR, Hobbs SC, Jenkins MR, Russell MG, Beer MS, Stanton JA, Scholey K, Hargreaves RJ, et al.

J Med Chem. 1994 Sep 16;37(19):3023-32.

PMID:
7932524
35.

L-694,247: a potent 5-HT1D receptor agonist.

Beer MS, Stanton JA, Bevan Y, Heald A, Reeve AJ, Street LJ, Matassa VG, Hargreaves RJ, Middlemiss DN.

Br J Pharmacol. 1993 Nov;110(3):1196-200.

36.
37.

5-HT1-like receptors: six down and still counting.

Beer MS, Middlemiss DN, McAllister G.

Trends Pharmacol Sci. 1993 Jun;14(6):228-31. Review. No abstract available.

PMID:
8372401
38.

Synthesis and serotonergic activity of 5-(oxadiazolyl)tryptamines: potent agonists for 5-HT1D receptors.

Street LJ, Baker R, Castro JL, Chambers MS, Guiblin AR, Hobbs SC, Matassa VG, Reeve AJ, Beer MS, Middlemiss DN, et al.

J Med Chem. 1993 May 28;36(11):1529-38.

PMID:
8496922
39.

5-Carboxamidotryptamine-insensitive 5-HT1-like receptors are concentrated in guinea pig but not rat, claustrum.

Beer MS, Stanton JA, Hawkins LM, Middlemiss DN.

Eur J Pharmacol. 1993 May 12;236(1):167-9.

PMID:
8319743
40.

Stereoselective actions of the isomers of metitepine at 5-HT1D receptors in the guinea pig brain.

Wilkinson LO, Hawkins LM, Beer MS, Hibert MF, Middlemiss DN.

Neuropharmacology. 1993 Mar;32(3):205-8.

PMID:
8474615
41.

Molecular cloning of a serotonin receptor from human brain (5HT1E): a fifth 5HT1-like subtype.

McAllister G, Charlesworth A, Snodin C, Beer MS, Noble AJ, Middlemiss DN, Iversen LL, Whiting P.

Proc Natl Acad Sci U S A. 1992 Jun 15;89(12):5517-21.

42.
43.

Interaction of the atypical neuroleptic clozapine with 5-HT3 receptors in the cerebral cortex and superior cervical ganglion of the rat.

Watling KJ, Beer MS, Stanton JA, Newberry NR.

Eur J Pharmacol. 1990 Jul 17;182(3):465-72.

PMID:
1977590
44.

Effects of clozapine and other neuroleptics on binding of [3H]-Q ICS 205-930 to central 5-HT3 recognition sites.

Watling KJ, Beer MS, Stanton JA.

Br J Pharmacol. 1989 Dec;98 Suppl:813P. No abstract available.

45.

Muscarinic M1, M2 receptor binding. Relationship with functional efficacy.

Freedman SB, Beer MS, Harley EA.

Eur J Pharmacol. 1988 Oct 26;156(1):133-42.

PMID:
3208836
46.

Pharmacologic exploitation of neurotransmitter receptors for the design of novel antidepressant drugs.

Palazidou E, Beer MS, Checkley S, Stahl SM.

Drug Des Deliv. 1988 May;2(4):247-56. Review.

PMID:
2908222
47.
48.

Effect of conjugated and unconjugated hyperbilirubinaemia on the plasma 25-hydroxy-vitamin D response to ultraviolet radiation in the rat.

Long RG, Barragry JM, Mitchenere P, Beer MS, Boucher BJ, Cohen RD.

Clin Sci (Lond). 1980 Oct;59(4):293-6.

PMID:
7428297

Supplemental Content

Support Center